Trial Profile
Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 12 Jun 2016 Planned End Date changed from 1 May 2014 to 1 Dec 2017.
- 12 Jun 2016 Planned primary completion date changed from 1 May 2014 to 1 Dec 2016.
- 12 Jun 2016 Status changed from recruiting to active, no longer recruiting.